Targeting host cells harbouring viruses with radiolabeled antibodies
- 3 May 2007
- journal article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 7 (5) , 595-597
- https://doi.org/10.1517/14712598.7.5.595
Abstract
Existing antiviral therapies produce a therapeutic effect by suppressing viral replication and reducing viral burden and the associated inflammatory reaction. However, infection with many viruses results in chronic infections that cannot be eradicated by the immune response or available antiviral drugs. As viruses are obligate intracellular pathogens, it should be possible to eradicate chronic infections by targeting and eliminating the infected host cells. Radioisotope-conjugated antibodies that specifically bind viral antigens can deliver cytotoxic radiation to virally infected cells. This approach was recently shown to target and eliminate HIV-1-infected cells in vitro and in mouse models, and provides a new approach for eliminating virally infected cells.Keywords
This publication has 8 references indexed in Scilit:
- Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral ProteinsPLoS Medicine, 2006
- Depletion of latent HIV-1 infection in vivo: a proof-of-concept studyThe Lancet, 2005
- Antibody-targeted radiation cancer therapyNature Reviews Drug Discovery, 2004
- In Vivo Efficacy of Anti-Glycoprotein 41, But Not Anti-Glycoprotein 120, Immunotoxins in a Mouse Model of HIV InfectionThe Journal of Immunology, 2003
- Use Of Recombinant Soluble Cd4 Pseudomonas Exotoxin, A Novel Immunotoxin, For Treatment Of Persons Infected With Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1994
- Failure Of Short-Term Cd4-Pe40 Infusions To Reduce Virus Load In Human Immunodeficiency Virus-Infected PersonsThe Journal of Infectious Diseases, 1994